Objectives: Recurring issues in clinical trial design may bias results toward the null, yielding findings inconclusive for treatment effects. This study evaluated for powering bias among high-impact critical care trials and the associated risk of masking clinically important treatment effects.
Design, Setting, And Patients: Secondary analysis of multicenter randomized trials of critically ill adults in which mortality was the main endpoint.